Table 3.
Polymeric micelle for cancer therapy in clinical trial or uses. Reproduced with permission from reference [62].
| Sr. No. | Product Name | Type | Drug | Status | Uses/Treatment |
|---|---|---|---|---|---|
| 1 | NK105 | PEG-PAA #
micelle |
Paclitaxel | Phase 2 or 3 | Breast cancer, Gastric cancer |
| 2 | NK911 | PEG-PAA micelle |
Doxorubicin | Phase 3 | Solid malignancies |
| 3 | NC-6004 | PEG-Polyglutamic acid | Cisplatin | Phase 3 | Pancreatic cancer |
| 4 | Genexol-PM | PEG-PLA #
micelle |
Paclitaxel | FDA # Approved | Breast cancer, ovarian and lung cancer |
# PEG-PAA micelle—Poly(ethylene glycol)-polyacrylic acid, PEG-PLA micelle—Poly(ethylene glycol)-polylactide micelles, FDA—Food and Drug Administration.